Is a complete INDP research report available?

No complete published report is available for Indaptus Therapeutics, Inc. (INDP) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Indaptus Therapeutics, Inc. (INDP)

NASDAQ: INDP · USD

$2.61

-0.16 (-5.8%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-26 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first INDP analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	295.6M
Net income (ttm)	-18.9M
EPS (ttm)	-$5.27
Shares out	113.2M
Volume	55,678
Beta	1.14

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -18.9M
EPS (ttm): -$5.27
Market cap: 295.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All INDP indicators

Market & fundamental data

Available fields

170

Groups with data

Currency

USD

Showing 170 of 170 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001857044
Company name	Indaptus Therapeutics, Inc.
Country	United States
Country code	US
Cusip	45339J204
Employees	5
Employees Change	-2%
Employees Change Percent	-28.57
Enterprise value	$294.1M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US45339J2042
Last refreshed	2026-07-26
Market cap	$295.6M
Market cap category	Micro-Cap
Price	$2.61
Price currency	USD
Sector	Healthcare
Sector PE	44.88
Sector PE Fwd	23.79
Sic	2834
Symbol	INDP
Website	https://indaptusrx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-6.38%
FCF yield	-5.68%
P/B ratio	236.86x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-18.9M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Profit Per Employee	$-3.8M
ROA	-286.8
Roa5y	-66.56
ROCE	-1,396
ROE	-931.8
Roe5y	-189.9
ROIC	-530.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-75.07%
Cagr3y	-63.19%
EPS Growth Quarters	7
EPS Growth Years	2
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$2.2M
Cash	$1.5M
Current Assets	$2.2M
Current Liabilities	$932,999
Debt	$0
Equity	$1.2M
Liabilities	$932,999
Long Term Assets	$0
Long Term Liabilities	$0
Net Cash	$1.5M
Net Cash By Market Cap	$0.51
Net Cash Growth	-60.91%
Net Debt Equity	$-1.2
Tangible Book Value	$1.2M
Tangible Book Value Per Share	$0.01
WACC	10.5

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.34
Net Working Capital	$-249,778
Quick ratio	1.61
Working Capital	$1.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-834.45%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-75.05%
200-day SMA	2.5
3Y total return	-95.02%
50-day SMA	2.61
50-day SMA vs 200-day SMA	50over200
All Time High	807.2
All Time High Change	-99.68%
All Time High Date	2021-09-15
All Time Low	0.92
All Time Low Change	183.7%
All Time Low Date	2026-05-22
ATR	0.36
Beta	1.14
Beta1y	1.69
Beta2y	1.91
Ch YTD	-10.31
High	2.88
High52	10.57
High52 Date	2025-07-28
High52ch	-75.31%
Low	2.57
Low52	0.92
Low52 Date	2026-05-22
Low52ch	183.7%
Ma50ch	0.19%
Premarket Change Percent	2.53
Premarket Price	$2.84
Premarket Volume	1,942
Price vs 200-day SMA	4.36%
RSI	47.05
RSI Monthly	24.13
RSI Weekly	47.32
Sharpe ratio	0.02x
Sortino ratio	0.08
Total Return	-834.45%
Tr YTD	-10.31
Tr1m	-29.65%
Tr1w	3.16%
Tr3m	-17.14%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$-1.57
Operating Income	$-17.4M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,243,132%
Float Percent	2.86%
Net Borrowing	5,714,800
Shares Insiders	97.14%
Shares Institutions	0.1%
Shares Out	113,242,324
Shares Qo Q	509.73%
Shares Yo Y	834.45%
Short Float	4.24%
Short Ratio	0.05
Short Shares	0.12

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-18.1M
Average Volume	78,004.35x
Bv Per Share	0.01
Ch1m	-29.65
Ch1w	3.16
Ch1y	-75.05
Ch3m	-17.14
Ch3y	-95.02
Ch6m	-3.69
Change	-5.78%
Change From Open	-9.38
Close	2.77
Days Gap	3.97
Dollar Volume	145,319.6
Earnings Date	2026-08-12
Earnings Time	bmo
EBIT	$-17.4M
EBITDA	$-17.4M
EPS	$-5.27
F Score	2
FCF	$-16.8M
FCF EV Yield	-5.71x
FCF Per Share	$-0.15
Financing CF	14,392,736
Fiscal Year End	December
Founded	2,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-15
Last Report Date	2026-03-31
Last Split Date	2025-06-27
Last Split Type	Reverse
Last10k Filing Date	2026-03-17
Ma150	2.37
Ma150ch	9.99%
Ma20	2.73
Ma20ch	-4.54%
Net CF	-2,393,386
Next Earnings Date	2026-08-12
Open	2.88
Optionable	No
Position In Range	14.29
Post Close	2.61
Postmarket Change Percent	-0.38
Postmarket Price	$2.6
Pre Close	2.77
Price Date	2026-07-24
Ptbv Ratio	236.9
Relative Volume	0.71x
Share Based Comp	1,344,371
Tr6m	-3.69%
Us State	New York
Volume	55,678

Indaptus Therapeutics, Inc. (INDP)

Coverage state: Market snapshot only — no published research

Generate the first INDP analysis

Price

Financial snapshot

Fair-value bridge

Latest news · INDP

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All INDP indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on INDP

Frequently asked questions